GlassScriptPhysician profile
James S Johnston
NPI 1467684423
$9,911.27
in general payments reported to CMS, 2019-2025
9 companies · $968 in 2025
The $968 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,652 · 2020: $14.33 · 2021: $2,733 · 2022: $50.97 · 2023: $950 · 2024: $2,543 · 2025: $968.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,652 · Food and Beverage: $809.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,652.38 |
| Food and Beverage | $808.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,749.98 | 2019-2025 | |
| Inari Medical, INC. | $1,485.30 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $949.85 | 2023 | Varithena Administration Pack |
| Paragon 28, INC. | $763.63 | 2020-2021 | |
| Sioux Surgical INC | $742.93 | 2024-2025 | |
| Rsw Medical Company, INC. | $131.01 | 2019 | |
| Smith+Nephew, INC. | $50.97 | 2022 | |
| Organogenesis INC. | $24.27 | 2025 | Puraply Wound Matrix |
| Osiris Therapeutics INC. | $13.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Johnston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.